What is the difference between Myo-inositol (Myoinositol) and D-chiro-inositol (D-chiroinositol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Both myo-inositol and D-chiro-inositol are beneficial for PCOS and insulin resistance, but they work best when used together in a 40:1 ratio that mimics their natural physiological balance, as supported by the most recent study 1.

Key Points

  • Myo-inositol primarily improves insulin sensitivity in muscles and helps with ovulation, while D-chiro-inositol works mainly in the liver and ovaries to regulate testosterone and improve ovarian function.
  • For most women with PCOS, a daily supplement containing 4000mg of myo-inositol and 100mg of D-chiro-inositol is recommended, though some may benefit from different ratios depending on their specific symptoms.
  • Myo-inositol alone (typically 2000-4000mg daily) can be effective for insulin resistance, fertility issues, and metabolic health, while D-chiro-inositol alone (500-1000mg daily) may help with hyperandrogenism symptoms like acne and hirsutism.
  • These supplements generally take 3-6 months to show full benefits and are considered safe with minimal side effects, mainly mild digestive discomfort that typically resolves with continued use, as reported in studies 2, 3, 4, 5.

Benefits of Combined Therapy

The combined therapy with myo-inositol and D-chiro-inositol has been shown to reduce the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone 5.

Important Considerations

  • The physiological ratio of myo-inositol to D-chiro-inositol is 40:1, which seems to be an optimal approach for the treatment of PCOS disorders 2.
  • The association of myo-inositol and D-chiro-inositol in a combination reproducing the plasma physiological ratio (40:1) represents a promising alternative in achieving better clinical results, by counteracting PCOS at both systemic and ovary level 4.

References

Research

Inositols in PCOS.

Molecules (Basel, Switzerland), 2020

Research

Inositol: history of an effective therapy for Polycystic Ovary Syndrome.

European review for medical and pharmacological sciences, 2014

Research

Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.